GLMD News and Press, Galmed Pharmaceuticals Ltd. From 08/14/23

2023-08-14 13:19:20 ET Despite recent setbacks, drugmakers are still forging ahead in their quest to develop effective treatments for non-alcoholic steatohepatitis, or NASH, a growing public health concern that could represent a roughly $108B global market opportunity by 2030. According...

2023-07-14 10:03:18 ET Galmed Pharmaceuticals ( NASDAQ: GLMD ) has priced a public offering of shares and warrants to raise $7 million, the company said Friday. The company entered into securities purchase agreements with two institutional investors to purchase 5.6 million ordin...

2023-07-14 10:01:23 ET Gainers: PainReform ( PRFX ) +112% . Acadia Pharmaceuticals ( ACAD ) +15% . Nutriband ( NTRB ) +14% . Arcturus Therapeutics ( ARCT ) +10% . Exicure ( XCUR ) +7% . Losers: Theseus Pharmaceuticals ( ...

Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering PR Newswire TEL AVIV, Israel , July 14, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metab...

2023-07-13 08:30:54 ET Ault Alliance ( AULT ) -35% announces a second partial distribution of TOG securities of approximately $0.37 for each share of ault alliance common stock. First Wave BioPharma ( FWBI ) -34% after Phase 2 setback for gut therapy. Cryop...

Galmed to employ OnKai's disruptive Artificial Intelligence (AI) in its Planned Phase 2a Clinical Trial in PSC PR Newswire OnKai's AI models redefine the methodologies and economics of clinical trials TEL AVIV, Israel , July 10, 2023 /PRNewswire/ -- Galme...

Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Developments PR Newswire TEL AVIV, Israel , June 1, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical...

2023-05-15 13:13:19 ET Gainers: Ohmyhome Limited ( OMH ) +169% . NeoGames ( NGMS ) +112% . GSI Technology ( GSIT ) +36% . Vaxart ( VXRT ) +34% . WiSA Technologies ( WISA ) +35% . Scilex Holding Company ( SCLX ) +31% ....

Galmed Announces Initiation of a Clinical Development Program to Evaluate Aramchol meglumine for the Treatment of Primary Sclerosing Cholangitis (PSC) PR Newswire The clinical research and development program will be conducted in collaboration with the Stravitz–Sanyal Ins...

2023-05-05 09:25:58 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Clearfield (NASDAQ: CLFD ) stock is falling on Friday after the passive connectivity products company released its earnings report for the fiscal second quarter of 2023. CLF...